The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDevit, D. C.
Right arrow Articles by Nikolajczyk, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDevit, D. C.
Right arrow Articles by Nikolajczyk, B. S.
The Journal of Immunology, 2005, 174: 2834-2842.
Copyright © 2005 by The American Association of Immunologists

The Ig{kappa}3' Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association1

Daniel C. McDevit*, Leslie Perkins{dagger}, Michael L. Atchison{dagger} and Barbara S. Nikolajczyk2,*,{ddagger}

* Department of Medicine, Immunobiology Unit, Evans Memorial Department of Clinical Research, Boston Medical Center, Boston, MA 02118; {dagger} Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104; and {ddagger} Department of Microbiology, Boston University School of Medicine, Boston, MA 02118

The Ig{kappa} locus is recombined following initiation of a signaling cascade during the early pre-B stage of B cell development. The Ig {kappa}3' enhancer plays an important role in normal B cell development by regulating {kappa} locus activation. Quantitative analyses of {kappa}3' enhancer chromatin structure by restriction endonuclease accessibility and protein association by chromatin immunoprecipitation in a developmental series of primary murine B cells and murine B cell lines demonstrate that the enhancer is activated progressively through multiple steps as cells mature. Moderate {kappa}3' chromatin accessibility and low levels of protein association in pro-B cells are increased substantially as the cells progress from pro- to pre-B, then eventually mature B cell stages. Chromatin immunoprecipitation assays suggest transcriptional regulators of the {kappa}3' enhancer, specifically PU.1 and IFN regulatory factor-4, exploit enhanced accessibility by increasing association as cells mature. Characterization of histone acetylation patterns at the {kappa}3' enhancer and experimental inhibition of histone deacetylation suggest changes therein may determine changes in enzyme and transcription factor accessibility. This analysis demonstrates {kappa} activation is a multistep process initiated in early B cell precursors before Igµ recombination and finalized only after the pre-B cell stage.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Zhang, S. Saccani, H. Shin, and B. S. Nikolajczyk
Dynamic Protein Associations Define Two Phases of IL-1{beta} Transcriptional Activation
J. Immunol., July 1, 2008; 181(1): 503 - 512.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ma, A. Turetsky, L. Trinh, and R. Lu
IFN Regulatory Factor 4 and 8 Promote Ig Light Chain {kappa} Locus Activation in Pre-B Cell Development
J. Immunol., December 1, 2006; 177(11): 7898 - 7904.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hodawadekar, F. Wei, D. Yu, A. Thomas-Tikhonenko, and M. L. Atchison
Epigenetic Histone Modifications Do Not Control Ig{kappa} Locus Contraction and Intranuclear Localization in Cells with Dual B Cell-Macrophage Potential
J. Immunol., November 1, 2006; 177(9): 6165 - 6171.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Pawlitzky, C. V. Angeles, A. M. Siegel, M. L. Stanton, R. Riblet, and P. H. Brodeur
Identification of a Candidate Regulatory Element within the 5' Flanking Region of the Mouse Igh Locus Defined by Pro-B Cell-Specific Hypersensitivity Associated with Binding of PU.1, Pax5, and E2A.
J. Immunol., June 1, 2006; 176(11): 6839 - 6851.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kersseboom, V. B. T. Ta, A. J. E. Zijlstra, S. Middendorp, H. Jumaa, P. Fokko van Loo, and R. W. Hendriks
Bruton's Tyrosine Kinase and SLP-65 Regulate Pre-B Cell Differentiation and the Induction of Ig Light Chain Gene Rearrangement.
J. Immunol., April 15, 2006; 176(8): 4543 - 4552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Liang, Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk
The Interleukin-1beta Gene Is Transcribed from a Poised Promoter Architecture in Monocytes
J. Biol. Chem., April 7, 2006; 281(14): 9227 - 9237.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Bai, L. Srinivasan, L. Perkins, and M. L. Atchison
Protein Acetylation Regulates Both PU.1 Transactivation and Ig{kappa} 3' Enhancer Activity
J. Immunol., October 15, 2005; 175(8): 5160 - 5169.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.